Aug 30, 2016 | Announcement, Funding, News
AbSci announced today that the company has finalized a lease agreement to relocate its headquarters to the new Hudson Building in downtown Vancouver, WA. AbSci expects to begin renovations by the beginning of September, and plans to take occupancy of the state-of-the-art lab facility by Q4 of this year, where the company will continue to develop and commercialize its revolutionary protein production technology.
May 2, 2016 | Announcement, News, Press
PORTLAND, Ore., May 2, 2016 /PRNewswire/ — AbSci announced today the appointment of V. Bryan Lawlis, Ph.D. to AbSci’s Board of Directors. Dr. Lawlis has been the CEO and founder of numerous biotechnology companies and currently serves on the Board of...
Apr 25, 2016 | Announcement, Funding
PORTLAND, Ore., April 25, 2016 /PRNewswire/ — AbSci, a global leader in soluble microbial protein expression has secured $5.1M in Series A financing led by Phoenix Venture Partners (PVP). Funding will accelerate commercialization of AbSci’s...
Oct 26, 2015 | Announcement, Award
Portland, OR — On October 22nd, the Oregon Entrepreneurs Network (OEN) held its 22nd Annual Tom Holce Entrepreneurship Awards, sending AbSci home with their Game Changer Award! During their gala, the OEN formally recognized the impact AbSci has had on...
